Skip to main content
OpenTrials

Clinical trial condition

Somatostatin Receptor-positive Neuroendocrine Tumor

Explore clinical trials studying Somatostatin Receptor-positive Neuroendocrine Tumor. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Somatostatin Receptor-positive Neuroendocrine Tumor trial results

Conditions
Somatostatin Receptor-positive Neuroendocrine Tumor
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Hirosaki, Aomori, Japan
  • Novartis Investigative Site Kamogawa, Chiba, Japan
  • Novartis Investigative Site Kashiwa, Chiba, Japan
View all 46 locations